Prehabilitation before elective cardiac interventions.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient 65 years of age or older in which one of the following elective cardiac interventions is planned: a) Replacement of heart valves by prosthesis (5-351) b) Replacement of heart valve prostheses (5-352) c) Valvuloplasty (5-353) d) Other operations on heart valves (5-354) e) Minimally invasive operations on heart valves (incl. catheter-based aortic valve implantation – TAVI and transvenous clip reconstruction of the mitral valve – MitraClip) (5-35a) f) Desobliteration (endarter-riectomy) of the coronary arteries (5-360) g) application of an aortocoronary bypass (5-361), h) application of an aortocoronary bypass by minimally invasive technique (5-362) or i) Other revascularization of the heart (5-363) 2. Sufficient independence and self-sufficiency capacity to participate in rehabilitation 3. Employment status: retired 4. Eligibility for consent 5. Willingness to participate voluntarily in studies after information with signed declaration of consent 6. Sufficient knowledge of the German language to complete/answer the questionnaires
Exclusion criteria
Exclusion criteria: 1. Lack of capacity to give consent 2. Katz-Index 0 3. Need for treatment in acute care hospital 4. Severe dementia; severe mental disorders (acute psychosis, major depressive episode, acute suicidality), acute delirium 5. Diagnosis of acute alcohol or drug abuse 6. Unstable angina pectoris 7. Heart failure, NYHA IV 8. Myocarditis, HOCM, main stem stenosis = 80% 9. Severe therapy-refractory cardiac arrhythmias 10. Condition after aortic dissection 11. PAD Stadium = III to Fontaine 12. Symptomatic carotid stenosis or carotid stenosis requiring treatment 13. Renal insufficiency requiring dialysis 14. Hepatic insufficiency, Child B and Child C 15. Advanced (metastatic) oncological disease 16. Neurological, orthopaedic or rheumatic debilitating comorbidities that speak against exercise training 17. Participation in another intervention study (participation in registry studies is allowed)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EQ-5D-5L (quality of life) and 1-year-mortality, both 12 months after cardiac intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| All following paramenters assessed 12 months after cardiac intervention: - EQ-VAS - Katz-Index (Daily function) - Heart Quality of Life Questionnaire (Heart-QoL) - Short Physical Performance Battery (SPPB) - Montreal Cognitive Assessment Test (MoCa) - Hospital Anxiety and Depression Scale (HADS) | — |
Countries
Germany
Contacts
Universitätsmedizin Göttingen, Klinik für Geriatrie